Dermata Therapeutics, Inc. Logo

Dermata Therapeutics, Inc.

Medical dermatology company developing and commercializing OTC skin care products.

DRMA | US

Overview

Corporate Details

ISIN(s):
US2498451085
LEI:
Country:
United States of America
Address:
3525 DEL MAR HEIGHTS RD., #322, 92130 SAN DIEGO

Description

Dermata Therapeutics is a medical dermatology company that has shifted its strategic focus to developing and commercializing scientifically-backed over-the-counter (OTC) pharmaceutical products. The company leverages its proprietary Spongilla technology, which combines natural elements with FDA-listed OTC ingredients to create differentiated skin care solutions. Its initial product is a once-weekly acne kit, supported by clinical validation from its Phase 3 START-1 trial. Dermata plans to expand its portfolio with product candidates for other common skin conditions, such as psoriasis and seborrheic dermatitis, aiming to provide patients with accessible and effective treatments to manage their skin health.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Dermata Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Dermata Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Dermata Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

GL Pharm Tech Corp. Logo
Develops incrementally modified drugs using advanced drug delivery technologies.
South Korea
204840
GNI  Group Ltd. Logo
Multinational biopharma firm developing drugs, TCMs, and medical devices.
Japan
2160
Goodwill Pharma Plc Logo
Develops, manufactures, and distributes medicines, supplements, and medical devices.
Hungary
GWPH
Gossamer Bio, Inc. Logo
Clinical-stage biopharma developing an inhaled therapy for pulmonary hypertension.
United States of America
GOSS
Grace Therapeutics, Inc. Logo
Late-stage biopharma developing drugs for rare and orphan neurological conditions.
United States of America
GRCE
Green Cross Corporation Logo
Develops protein therapeutics, vaccines, diagnostics, and consumer health products.
South Korea
006280
A holding company in biopharma, diagnostics, consumer, and digital healthcare.
South Korea
005250
GREEN CROSS WellBeing Corporation Logo
Develops nutritional injections, health supplements, and cosmetics.
South Korea
234690
Greenwich LifeSciences, Inc. Logo
A clinical-stage biopharma developing immunotherapies to prevent cancer recurrence.
United States of America
GLSI
GRI Bio, Inc. Logo
Develops NKT cell modulators for inflammatory, fibrotic, and autoimmune diseases.
United States of America
GRI

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.